Bax, BE
(2017)
Drug Development for Rare Diseases: Challenges and Regulatory Initiatives.
Archives of Science, 1 (2).
p. 107.
https://doi.org/10.4172/science.1000107
SGUL Authors: Bax, Bridget Elizabeth
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (361kB) | Preview |
| Item Type: | Article | ||||||
|---|---|---|---|---|---|---|---|
| Additional Information: | Copyright: © 2017 Bax BE. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | ||||||
| SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) | ||||||
| Journal or Publication Title: | Archives of Science | ||||||
| Dates: |
|
||||||
| Publisher License: | Creative Commons: Attribution 4.0 | ||||||
| URI: | https://openaccess.sgul.ac.uk/id/eprint/111027 | ||||||
| Publisher's version: | https://doi.org/10.4172/science.1000107 |
Statistics
Item downloaded times since 24 Jul 2019.
Actions (login required)
 |
Edit Item |